Third-Line Therapy in Metastatic Colorectal Cancer
N Engl J Med
.
2023 Jul 13;389(2):190.
doi: 10.1056/NEJMc2306486.
Authors
Joris van de Haar
1
,
Nicola Valeri
2
,
Emile E Voest
3
Affiliations
1
Netherlands Cancer Institute, Amsterdam, the Netherlands j.vd.haar@nki.nl.
2
Institute of Cancer Research, London, United Kingdom.
3
Netherlands Cancer Institute, Amsterdam, the Netherlands.
PMID:
37437152
DOI:
10.1056/NEJMc2306486
No abstract available
Publication types
Letter
Comment
MeSH terms
Bevacizumab
Colorectal Neoplasms* / drug therapy
Humans
Trifluridine*
Substances
tipiracil
Trifluridine
Bevacizumab